Overview
Platango seeds refer to the seeds collected from various species of plantago trees. It is found in some laxatives for treating occasional constipation and restoring regularity in bowel movements. Its potential benefit in maintaining remission in ulcerative colitis has been studied . Regardless, this agent is most predominantly used as a gentle laxative agent in many parts of the world that is more commonly referred as psyllium or psyllium husk.
Indication
Indications include the treatment of patients needing a high fibre regime, perhaps for: (a) the relief of constipation, including constipation in pregnancy and the maintenance of regularity; (b) the management of bowel function in patients with colostomy, ileostomy, hemorrhoids, anal fissure, chronic diarrhea with diverticular disease, irritable bowel syndrome, and ulcerative colitis .
Associated Conditions
- Bowel Motility
- Constipation
Research Report
A Comprehensive Pharmacological and Clinical Monograph on Plantago Seed (Psyllium)
Botanical Origin and Substance Identification
The therapeutic agent commonly known as Plantago seed or psyllium is a natural product with a long history of use in traditional medicine that has transitioned into a well-established, evidence-based therapy in modern clinical practice. Its identity is complex, defined by a variety of names, multiple botanical source species, and specific pharmacopoeial characteristics. A precise understanding of its origin and identification is fundamental to its safe and effective use.
Nomenclature, Synonyms, and Commercial Identity
The substance is derived from the seeds of plants belonging to the Plantago genus and is referred to by a wide array of names that reflect its global use and different preparations.[1] While "Plantago seed" is a correct botanical descriptor, the most prevalent common name in commerce and clinical literature is "psyllium".[1] Other significant synonyms include Ispaghula or Isabgol, particularly in the context of its use in South Asia, and Fleaseed, a historical European term.[3]
It is critical to distinguish between the different parts of the seed used therapeutically. The term "psyllium husk" or "seed coat" refers specifically to the episperm and collapsed adjacent layers removed from the ripe seeds.[1] This husk is the primary source of the active mucilaginous fiber and is the component most frequently used in over-the-counter laxative preparations and dietary supplements.[1] "Psyllium seed" may refer to the whole, dried, ripe seed, which contains the husk as well as the nutrient-rich endosperm and embryo.[6] "Psyllium gum" typically refers to the extracted and purified polysaccharide mucilage itself.[8]
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/10/15 | Phase 2 | Recruiting | Dr Bruno Chumpitazi, M.D. | ||
2023/12/12 | Phase 2 | Not yet recruiting | |||
2023/05/22 | Phase 4 | Completed | |||
2018/09/13 | Phase 4 | Completed | West Side Institute for Science and Education | ||
2016/08/16 | Not Applicable | Completed | Amsterdam UMC, location VUmc | ||
2014/05/22 | Phase 2 | Terminated | |||
2014/05/13 | Phase 4 | Completed | Francesco Gabrielli | ||
2010/12/02 | Phase 4 | Completed | |||
2008/08/04 | Phase 2 | Completed | |||
2005/09/16 | Not Applicable | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Raritan Pharmaceuticals Inc | 68163-571 | ORAL | 3.4 g in 12 g | 4/8/2025 | |
| LIDL US, LLC | 71141-145 | ORAL | 3.4 g in 12 g | 9/19/2025 | |
| LIDL US, LLC | 71141-146 | ORAL | 3.4 g in 5.8 g | 9/19/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| METAMUCIL (psyllium hydrophillic mucilloid) smooth texture orange powder jar | 68398 | Proqualix Pty Ltd - in Administration | Medicine | A | 3/17/1999 |
| Spring Leaf Fat Clear | 292279 | Medicine | A | 8/1/2017 | |
| Gut Health Fibre Supplement Psyllium husk powder 550mg (per capsule) | 491949 | Medicine | A | 6/17/2025 | |
| LIVE TONIC VITAMIN B COMPLEX | 148298 | Medicine | A | 12/10/2007 | |
| METAMUCIL LEMON LIME SMOOTH psyllium husk powder 578mg/g jar | 47538 | Medicine | A | 1/19/1994 | |
| METAMUCIL FIBRECAPS | 316480 | Medicine | A | 4/15/2019 | |
| SlimVibe | 499010 | Medicine | A | 7/9/2025 | |
| NUCOLOX oral powder | 63979 | Medicine | A | 5/11/1998 | |
| Swisse Ultiboost Fibre Cleanse | 450365 | Medicine | A | 5/31/2024 | |
| Elite Fibre Cleanse | 468465 | Medicine | A | 11/13/2024 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| MULTILAX 1 CAP | nature's way of canada ltd. | 00629561 | Capsule - Oral | 378 MG / CAP | 12/31/1984 |
| HM-LAX CAP 435MG | nutrition professionals inc. | 00643807 | Capsule - Oral | 435 MG / CAP | 12/31/1988 |
| FIBRE LAXATIVE EXTRA SMOOTH-PWR 3.4GM/12GM | vita health products inc | 02157276 | Powder - Oral | 3.4 G / 12 G | 12/31/1995 |
| SSMO COMPLEX DPS | thompson's homeopathic supplies ltd. | 00757381 | Drops - Oral | 3 X / X | 12/31/1987 |
| PSYLLIUM BLOND | laboratoire atlas inc | 00050172 | Seed - Oral | null NIL / NIL | 12/31/1951 |
| PRODIEM PLUS POWDER | rhone-poulenc rorer consumer inc. | 01937626 | Powder - Oral | 542 MG / G | 12/31/1993 |
| PLANTAGO MAJOR GRANULE 1DH - 30CH | dolisos laboratoires s.a. | 00699160 | Tablet - Oral | 1 DH / DH | 12/31/1987 |
| PLANTAGO MAJOR GOUTTE 4CH-30CH | dolisos laboratoires s.a. | 00684260 | Drops - Oral | 1 CH / CH | 12/31/1987 |
| NAT.SOURCE FIBRE LAX.SM.TEX.-SUGAR FREE | stanley pharmaceuticals, a division of vita health products inc. | 02067552 | Powder - Oral | 3.4 G / 5.8 G | 12/31/1995 |
| NATURAL SOURCE LAXATIVE PWR | novopharm limited | 00551546 | Powder - Oral | 3 G / 6.2 G | 12/31/1989 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.
